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Stabilization of apoptotic cells: generation
of zombie cells
M Oropesa-A´vila1, Y Andrade-Talavera2, J Garrido-Maraver1, MD Cordero3, M de la Mata1, D Cota´n1, MV Paz1, AD Pavo´n1,
E Alcocer-Go´mez1, I de Lavera1, R Lema1, AP Zaderenko4, A Rodrı´guez-Moreno2 and JA Sa´nchez-Alca´zar*,1
Apoptosis is characterized by degradation of cell components but plasma membrane remains intact. Apoptotic microtubule
network (AMN) is organized during apoptosis forming a cortical structure beneath plasma membrane that maintains plasma
membrane integrity. Apoptotic cells are also characterized by high reactive oxygen species (ROS) production that can be
potentially harmful for the cell. The aim of this study was to develop a method that allows stabilizing apoptotic cells for diagnostic
and therapeutic applications. By using a cocktail composed of taxol (a microtubule stabilizer), Zn2þ (a caspase inhibitor) and
coenzyme Q10 (a lipid antioxidant), we were able to stabilize H460 apoptotic cells in cell cultures for at least 72 h, preventing
secondary necrosis. Stabilized apoptotic cells maintain many apoptotic cell characteristics such as the presence of apoptotic
microtubules, plasma membrane integrity, low intracellular calcium levels and mitochondrial polarization. Apoptotic cell
stabilization may open new avenues in apoptosis detection and therapy.
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Apoptosis, also known as programmed cell death, is central to
homoeostasis and normal development and physiology in
multicellular organisms, including humans.1 The dysregula-
tion of apoptosis can lead to the destruction of normal tissues
in a variety of disorders, including autoimmune and neuro-
degenerative diseases (increased apoptosis) or cancer
(reduced apoptosis). In addition, effective therapy of tumors
requires the iatrogenic induction of apoptosis by radiation,
chemotherapy or both. In particular, many antineoplasic drugs
such as campothecin, a topoisomerase I inhibitor, kill tumor
cells by inducing apoptosis.
Apoptosis is thought to be physiologically advantageous
because apoptotic cells are removed by phagocytosis before
they lose their permeability barrier, thus preventing induction
of an inflammatory response to the dying cells and potential
harmful secondary effects. However, whenmassive cell death
overwhelms macrophage clearance, as for example in early
postchemotherapy or viral infection,2 apoptotic cells may
progress to secondary necrosis characterized by cell mem-
brane degradation with spillage of intracellular contents to the
extracellular milieu.3 Similarly, cells undergoing apoptosis
in vitro cannot usually be cleared by phagocytes and undergo
a late process of secondary necrosis.4
In the execution phase of apoptosis, effector caspases
cleave vital cellular proteins, leading to the morphological
changes that characterize apoptosis. These changes include
destruction of the nucleus and other organelles, DNA
fragmentation, chromatin condensation, cell shrinkage, cell
detachment and membrane blebbing.5 In apoptosis, all the
degradative processes are isolated from the extracellular
space by the plasma membrane that remains impermeable.
However, the mechanisms involved in plasmamembrane and
associated protein protection from the action of caspases are
not completely understood. In contrast, necrosis is accom-
panied by disruption of plasma membrane integrity with the
subsequent release of all intracellular compounds to the
intercellular space, thus inducing inflammation and more toxic
effects to adjacent cells.6,7
To allow the dramatic morphological changes that accom-
pany the execution phase, an apoptotic cell undergoes a
series of profound cytoskeletal breakdowns/rearrangements.
Previous evidence suggests that the actomyosin cytoskeleton
plays an essential role in apoptotic cell remodeling during the
early events of the execution phase, whereas all other
cytoskeleton elements (microtubules and intermediate fila-
ments) are dismantled.8 However, during the course of the
execution phase and after actininomyosin ring contraction, the
actomyosin filaments are also depolymerized by a caspase-
dependent mechanism. In this situation, the apoptotic cell
forms a network of apoptotic microtubules that becomes the
main cytoskeleton element of the apoptotic cell. The presence
of microtubules in apoptotic cells has previously been
reported.9,10 Moreover, more recent results indicate that
microtubules during apoptosis assist in the dispersal of
nuclear and cellular fragments,11,12 and may help to preserve
the integrity of plasma membrane of the dying cell.13
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Reactive oxygen species (ROS) are also important media-
tors of apoptosis. ROS have been shown to play a major role
in apoptosis signaling.14–16 Electron leak in the presence of
oxygen during the process of oxidative phosphorylation make
mitochondria themajor endogenous source of ROS in the cell.
Although mitochondria have been identified as a key player,
the mechanism connecting ROS and apoptosis remains
unclear.17 It has been debated whether increased ROS
during apoptosis is a cause or a consequence of impaired
mitochondrial function, and whether ROS are a death signal to
the mitochondria or are produced as effector molecules by the
mitochondria in response to apoptosis signal.18,19 Hyperpro-
duction of ROS in execution stages of apoptosis is thought to
be caused by the disruption of the mitochondrial respiratory
chain after release of cytochrome c into the cytosol.20
Themain objective of this work was to develop a method for
the stabilization of apoptotic cells for proper apoptosis
detection or safer potential therapeutic applications. Our
results show that apoptotic cells can be stabilized by a cocktail
of a microtubule stabilizer (taxol), a caspase inhibitor such
(Zn2þ ) and an antioxidant (coenzyme Q10 (CoQ)).
Results
Plasma membrane and the cellular cortex are preserved
during apoptosis. To examine the arrangement of micro-
tubules during the execution phase of apoptosis and its
relationship with plasma membrane, control and camptothe-
cin (CPT)-induced apoptotic H460 cells were fixed and
stained for b-tubulin and active caspase-3. Wheat germ
agglutinin fluorescent conjugated that selectively recognizes
sialic acid and N-acetylglucosaminyl sugar residues was
used to reveal plasma membrane (Figures 1a and b). In
control cells, caspase-3 was not activated and microtubules
showed their typical interphase radial organization. In
apoptotic cells, caspase-3 was activated and the microtu-
bules were reorganized beneath plasma membrane forming
the apoptotic microtubule network (AMN). Apoptotic micro-
tubules seemed to work as a physical barrier impeding the
access of active caspases to the cellular cortex and plasma
membrane (Figure 1b). The cellular cortex that appears as a
narrow area between the plasma membrane and the
apoptotic microtubules was free of active caspase-3.
Altogether, these results suggest that if the cellular cortex
is maintained free of the action of caspases by AMN
stabilization and/or caspase inhibition, apoptotic cell integrity
could be preserved for longer periods of time.
Increased ROS generation during apoptosis. To examine
ROS generation during the execution phase of apoptosis,
control and apoptotic H460 cells were stained with MitoSOX,
a mitochondrial superoxide fluorescent indicator, and ana-
lyzed by fluorescence microscopy and flow cytometry.
Figures 1c and d clearly show a notable increase of ROS
production in apoptotic cells. These data suggest that
antioxidants could be useful for protection and stabilization
of apoptotic cells.
Stabilization of apoptotic cells. Previously, we have
demonstrated that the execution phase in CPT-induced
apoptosis lasts between 50 and 158min and is characterized
by the presence of the AMN, high mitochondrial polarization
and low intracellular calcium levels.21 When apoptotic cells
undergo secondary necrosis, AMN is disorganized, mito-
chondrial potential collapses and calcium levels increase,
suggesting the loss of plasma membrane integrity
(Supplementary Figure 1a).
For the temporal stabilization and longer preservation of
cells in apoptosis, apoptotic H460 cells were treated with 1 mM
taxol, a microtubule-stabilizing agent to prevent AMN depo-
lymerization, 50 mM Zn2þ , a caspase inhibitor to prevent
extensive degradation of cellular components and caspase-
dependent cleavage of cellular cortex and plasma membrane
proteins or 50 mM CoQ, a lipid-derived antioxidant to protect
membranes from oxidative stress or a combination of the
three compounds (Supplementary Figure 1b).
Stabilization of apoptotic cells preserves cell attachment
and cell content release. First, we obtained a homoge-
neous synchronized population of H460 apoptotic cells for
subsequent stabilization. To do this, we used the apoptotic
cell enrichment assay previously described by our group.13
Once we had a homogeneous apoptotic cell population, cells
were treated with taxol (1 mM), Zn2þ (50mM) or CoQ (50mM)
or with a cocktail composed of the three compounds. After
the stabilization treatment, apoptotic cells were incubated for
72 h and then we examined the number of apoptotic cells that
remained attached to the coverslip by light microscopy and
the intracellular content release to the medium by measuring
(lactate dehydrogenase (LDH) activity by using spectro-
photometry (Figures 2a–c). After 72 h of incubation, most of
apoptotic cells without stabilization were detached (Figures
2a and b) from the coverslip and underwent secondary
necrosis that was confirmed by the significant increase of
LDH release (Figure 2c). On the contrary, stabilization of
apoptotic cells by taxol, Zn2þ or CoQ and more significantly
the combined treatment with all the three compounds
reduced cell detachment from the coverslip and a decreased
LDH release to the medium, suggesting that plasma
membrane integrity was maintained after 72 h of incubation.
These results indicated that an apoptotic-stabilizing cocktail
composed of taxol, Zn2þ and CoQ (apoptotic stabilizer) can
be used for apoptotic cell preservation. Stabilized apoptotic
cells could be maintained in culture for 96 h (Supplementary
Figures 2a and b). After 96 h of incubation, stabilized
apoptotic cells underwent secondary necrosis that was
characterized by a marked increase of cell detachment and
LDH release. Apoptotic cell stabilization was also confirmed
in CPT-induced apoptotic HeLa cells (Supplementary
Figures 3a–c).
Stabilization of apoptotic cells prevents plasma mem-
brane permeability. To confirm apoptotic cell stabilization
by the combined treatment of taxol, Zn2þ and CoQ after 72 h
of incubation, we examined plasma membrane permeability
in both stabilized apoptotic cells and apoptotic cells without
stabilization. Cells were examined using the Dead Red
reagent, a red fluorescent nucleic acid stain that only labels
permeable cells, thus testing plasma membrane integrity.22
These observations were quantified by scoring the proportion
AMN stabilization
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Figure 1 AMN, caspase activation and ROS production during the execution phase of apoptosis. (a) Fluorescence microscopy of microtubules, plasma membrane and
active caspase-3 in H460 control and apoptotic cells. H460 cells were grown on glass coverslips and apoptosis was induced as described in the enriched apoptotic assay in the
Materials and Methods. Then, cells were fixed and immunostained with anti b-tubulin (green), anti-active caspase-3. Plasma membrane was revealed by staining with WG
agglutinin. Nuclear morphology was revealed by staining with Hoechst 33342 (1mg/ml). (b) Magnification of H460 apoptotic cells. (c) Fluorescence microscopy of ROS
production in H460 control and apoptotic cells. H460 cells were grown on glass coverslips and apoptosis was induced as described in the enriched apoptotic assay in the
Materials and Methods. Then, cells were incubated with MitoSOX. After fixation, cells were immunostained with anti b-tubulin (green). Nuclear morphology was revealed by
staining with Hoechst 33342 (1mg/ml). Bar¼ 15mm. (d) ROS levels in H460 control and apoptotic cells were determined by flow cytometry using MitoSOX staining, as
described in the Materials and Methods. The y axis of the MitoSOX graph represents the fluorescence intensities of MitoSOX cell samples relative to unstained cells. Data
represent means±S.D. of three separate experiments. **Po0.01 versus control
AMN stabilization
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Figure 2 Effect of apoptotic cell stabilization on cell attachment and intracellular content release. Attached cells (a and b) and LDH release (c) in control cells, apoptotic
cells without stabilization and apoptotic cells plus 1 mM taxol or 50mM Zn2þ or 50mM CoQ or a combination of all of them after 72 h of incubation. H460 cells were grown on
glass coverslips and apoptosis was induced as described in the enriched apoptotic assay in the Materials and Methods. For apoptotic cell stabilization, apoptotic cells were
treated with taxol, Zn2þ and CoQ. Attached cells were scored by microscopy examination. LDH determination in the cultured medium was assessed as described in the
Materials and Methods. *Po0.01, significant differences with respect to control cells; aPo0.01, significant differences with respect to apoptotic cells without stabilization
AMN stabilization
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of permeable and nonpermeable cells. We found that
stabilized apoptotic cells maintained the AMN and were also
nonpermeable to the supravital dye (Figures 3a and b). On
the contrary, we observed that membrane integrity was
impaired in apoptotic cells without stabilization and in control
secondary necrotic cells in which AMN was clearly disorga-
nized (Figures 3a and b). As expected, control cells remained
nonpermeable.
Plasma membrane and cell cortex proteins are protected
from caspase-mediated cleavage by apoptotic stabilizer.
To verify the integrity of cellular cortex and plasma
membrane proteins in stabilized apoptotic cells by the
combined treatment of taxol, Zn2þ and CoQ (apoptotic
stabilizer) for 72 h, we examined the integrity of well-known
cellular cortex and plasma membrane proteins that are
common substrates of effector caspases when apoptotic
cells undergo secondary necrosis.23 Western blotting analy-
sis revealed that initiator caspase-9 and effector caspases-3
and -7 were activated and that nuclear (PARP) and cytosolic
proteins (Rho-associated, coiled-coil containing protein
kinase 1 (ROCK-1)) were cleaved in apoptotic cells with
and without stabilization treatment and also in control
secondary necrotic cells, thus indicating that active caspases
had degraded nuclear and cytosolic components during the
execution phase of apoptosis (Figure 3c). However, cellular
cortex and transmembrane proteins such as a-spectrin,
paxilin and plasma membrane Ca2þ ATPase (PMCA-4)
were only cleaved when AMN was disorganized in apoptotic
cells without stabilization or in control secondary necrotic
cells. On the contrary, cellular cortex and plasma membrane
proteins were intact in stabilized apoptotic cells that maintain
the AMN (Figure 3c). Together, these data indicate that
apoptotic cells can be stabilized maintaining the integrity of
cellular cortex and plasma membrane proteins.
Apoptotic cell stabilization prevents PMCA-4 cleavage
and calcium overload. To confirm plasma membrane
protein integrity, we performed immunofluorescence analysis
of PMCA-4, a plasma membrane protein involved in calcium
extrusion. PMCA-4 integrity was visualized in stabilized
apoptotic cells by the combined treatment of taxol, Zn2þ
and CoQ (apoptotic stabilizer) versus nonstabilized apoptotic
cells after 72 h of incubation. Previously, we have demon-
strated that PMCA-4 remains intact during the execution
phase of apoptosis and is only degraded when cells undergo
secondary necrosis.23 As shown in Figure 4a, stabilized
apoptotic cells maintain the AMN and the integrity of PMCA-4.
On the contrary, the fluorescent signal of PMCA-4
disappears in apoptotic cells without stabilization and in
control secondary necrotic cells in which the AMN was
disorganized.
To confirm plasma membrane integrity and PMC-4 func-
tionality, we measured intracellular calcium levels by FLUO-4
staining. Stabilized apoptotic cells showed a moderate
increase of FLUO-4 fluorescence with respect to control cells.
However, apoptotic cells without stabilization or control
secondary necrotic cells showed a notable increase of
FLUO-4 fluorescence suggesting increased plasma mem-
brane permeability and calcium overload (Figure 4b).
Mitochondrial membrane potential (Dwm), ATP levels
and ROS production in stabilized apoptotic cells. We
have previously demonstrated that AMN during apoptosis
depends on energized mitochondria.21 Here, we have found
that in stabilized apoptotic cells by the combined treatment of
taxol, Zn2þ and CoQ (by the action of the described
apoptotic stabilizer), mitochondria maintain a degree of
polarization, although this was significantly reduced com-
pared with control cells (Figure 4c). On the contrary, when
AMN was disorganized in apoptotic cells without stabilization
or in control secondary necrotic cells, a marked mitochondrial
depolarization was found (Figure 4c). These results suggest
that mitochondrial large depolarization observed during
secondary necrosis was significantly prevented in stabilized
apoptotic cells. Stabilized apoptotic cells also showed
increased ATP levels with respect to secondary necrotic
cells, although they were significantly reduced with respect to
control cells (Figure 4d). ROS production was also signifi-
cantly reduced in stabilized apoptotic cells with respect to
genuine apoptotic and necrotic cells (Figure 4e).
High phosphatidylserine exposure in stabilized apopto-
tic cells. Phosphatidylserine (PS) is actively localized on the
inner leaflet of the plasma membrane in healthy cells. The
asymmetry of its distribution is lost in apoptotic cells. To
examine PS exposure in stabilized apoptotic cells by the
combined treatment of taxol, Zn2þ and CoQ (apoptotic
stabilizer), we analyzed the binding of Annexin V-FITC to PS
by using immunofluorescence and flow cytometry analysis in
control, apoptotic cells without stabilization, stabilized apop-
totic cells and control secondary necrotic cells. We have
found that PS was highly translocated in stabilized apoptotic
cells. However, PS translocation was significantly reduced in
apoptotic cells without stabilization or in cells suffering
secondary necrosis. As expected, control cells did not show
PS externalization (Figures 5a and b).
Stabilized apoptotic cells interact with macrophages. As
apoptotic cell stabilization effectively allows high PS exter-
nalization, we also tested their binding and uptake by
phagocytes. In control, apoptotic cells without stabilization
or in control secondary necrotic cells, that is, associated with
low PS externalization, the proportion of macrophages
interacting with and engulfing apoptotic cells was markedly
reduced as compared with stabilized apoptotic cells by the
combined treatment of taxol, Zn2þ and CoQ with high PS
externalization (Figures 5c and d ).
Stabilized apoptotic cells maintain plasma membrane
potential. To evaluate the effect of apoptotic stabilization on
cell plasma membrane potentials, we performed patch-clamp
recordings in H460 control, genuine apoptotic cells before
stabilization and stabilized apoptotic cells (stabilized as
indicated above by the combined treatment with taxol,
Zn2þ and CoQ). To acquire information of baseline and to
monitor membrane potential (Vm) at rest, cells were recorded
for periods of 20min using the current-clamp mode of the
whole-cell configuration of the patch-clamp technique
(Figure 6a). Vm was very stable during recordings. H460
control cells showed a Vm of  52±2 and  55±2mV at 0
AMN stabilization
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Figure 3 Effect of apoptotic cell stabilization on plasma membrane permeability and protein integrity. (a) Fluorescence microscopy of microtubules and plasma membrane
permeability in control cells, apoptotic cells without stabilization, apoptotic cells plus stabilizer and secondary necrotic cells after 72 h of incubation. H460 cells were grown on
glass coverslips and apoptosis was induced as described in the enriched apoptotic assay in the Materials and Methods. For apoptotic cell stabilization, apoptotic cells were
treated with 1mM taxol, 50mM Zn2þ and 50mM CoQ and incubated for 72 h. Control secondary necrotic cells were collected from the floating cells in the medium after
treatment with CPT and cytospined on a slide. Before fixation, cells were treated with the Dead Red dye, and then fixed and immunostained with mouse anti-b-tubulin (green).
Nuclear morphology was revealed by staining with Hoechst 33342 (1mg/ml). Bar¼ 15mm. (b) Proportion of Dead Red negative (nonpermeable plasma membrane), and
Dead Red positive (permeable plasma membrane) in control, apoptotic cells without stabilization, stabilized apoptotic cells and control secondary necrosis H460 cells. More
than 100 cells were examined for each experimental condition. *Po0.01, significant differences with respect to control cells; aPo0.01, significant differences with respect to
apoptotic cells. (c) Western blotting of nuclear (PARP), cytosolic (ROCK-1) and cellular cortex proteins (spectrin, FAK and paxilin) and plasma membrane proteins (PMC-4) in
control cells, apoptotic cells without stabilization, stabilized apoptotic cells and control secondary necrotic cells after 72 h of incubation. Apoptosis in H460 cells was induced as
described in the enriched apoptotic assay in the Materials and Methods. Control secondary necrotic cells were collected from the floating cells in the medium after the
treatment. For stabilization, apoptotic cells were treated with 1 mM taxol, 50mM Zn2þ and 50mM CoQ. Cell lysates were resolved by SDS-PAGE and protein levels and
cleavage fragments (arrows) were determined by western blotting. Equal loading and transfer were shown by repeat probing with anti-actin
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and 20min after the beginning of the recordings, respectively
(n¼ 11). In genuine apoptotic cells before stabilization, the
Vm was significantly depolarized compared with control cells
( 16±3 and  17±2mV at 0 and 20min, n¼ 6). In
stabilized apoptotic cells, the Vm was significantly depolar-
ized compared with control cells but very similar to apoptotic
cells before stabilization, maintaining a membrane potential
of  17±3 and  14±3mV at 0 and 20min after the
beginning of the recordings, respectively (n¼ 7; Figure 6b).
Secondary necrotic cells had a membrane potential close to
0mV ( 1±0.5 and  2±0.1mV at 0 and 20min, n¼ 3). To
better characterize the electrical properties of the cells,
series resistance was monitored and measured during
recordings. No changes in series resistance were found
during the course of the experiments. Average series
resistances were 26±2, 24±1 23±2 and 25±1MO for
control, apoptotic cells before stabilization, stabilized apop-
totic cells and secondary necrotic cells, respectively, indicat-
ing that the apoptotic treatment did not induce any change in
this parameter (Figure 6c). These results indicate that
stabilization of apoptotic cells helps to maintain the values
of series resistance, thus contributing to the maintaining of a
membrane potential by apoptotic cells.
We next studied the passive membrane properties of
control, apoptotic cells before stabilization and stabilized
apoptotic cells. For this purpose, a series of test pulses was
applied with 10mV increases in the pulse amplitude per step.
According to nonexcitable cell behavior, there was no action
potential occurrence at depolarizing potentials (Figure 6d).
Furthermore, no occurrence of local potential or other
spontaneous activity was observed at very depolarized or
hyperpolarized membrane potentials ranging from  100 to
þ 40mV (Figure 6e).
It is clear from our results that the induction of apoptosis in
H460 cells by CPT produces changes in the Vm of the cells.
The fact that the stabilized apoptotic cells still maintain the
same level of Vm than apoptotic cells before stabilization is
indicating that the cells are not physiologically dead and that
some of the physiological processes of the cell involving the
crossing of ions (sodium and potassium ions) and the plasma
membrane pump are most probably still working, also
indicating that stabilization of apoptotic cells may delay the
loss of membrane potential.
Stabilization of apoptotic cells prevents secondary
necrosis and allows reliable apoptosis quantification
by flow cytometry. It is well known that reliable apoptotic
quantification in adherent cell cultures by flow cytometry is
difficult and unreliable because of the fact that during the
process of cell harvesting and manipulation before and
during flow cytometry assays many apoptotic cells undergo
secondary necrosis. Therefore, we decided to examine the
effect of the stabilizer cocktail in apoptosis quantification by
flow cytometry.
With the aim of stabilizing apoptotic cells for reliable
diagnostic detection and quantification of apoptosis, we first
induced a high population of apoptotic H460 cells by treatment
with 10 mM CPT for 48 h. Subsequently, apoptotic cells were
incubated in the absence and presence of apoptotic stabilizer
(taxolþZn2þ þCoQ) for 10min before harvesting. Then, we
quantified apoptotic cells and cells in secondary necrosis by
flow cytometry by staining with Annexin-FITC and
7-aminoactinomycin (7-AAD) following the standard protocol
described in the Materials and Methods section
(Supplementary Figures 4a and b). Results showed that
during the process of cell harvesting and manipulation during
the flow cytometry assay, many apoptotic cells without
stabilization underwent secondary necrosis (42%). However,
the treatment of apoptotic cells with the stabilizer 10min
before harvesting significantly prevented plasma membrane
disruption and secondary necrosis (8%). These data suggest
that stabilization of apoptotic cells may be a very useful tool for
reliable apoptosis quantification by flow cytometry assays.
Discussion
In the present study, we have developed and described an
innovative method aimed to the temporal stabilization and
preservation of apoptotic cells. This method consists of the
combined treatment of apoptotic cells with taxol, Zn2þ and
CoQ. This experimental approach guarantees apoptotic cell
integrity by preventing plasma membrane permeability and
secondary necrosis.
The rationale for using this stabilizing combination was: (1)
the use of taxol that, as a microtubule- stabilizing agent,24,25
prevents AMNdepolymerization and subsequently the access
of active caspases to the cellular cortex; (b) the use of Zn2þ
that, as a caspase inhibitor,26–29 prevents extensive degrada-
tion of cellular components and caspase-dependent cleavage
of cellular cortex and plasma membrane proteins; and (3) the
use of CoQ that, as an antioxidant,30 protects against
oxidative membrane damage that is increased in apoptotic
cells.
Stabilized apoptotic cells can be considered as dying cells
in which the cellular cortex and plasma membrane are
maintained intact or alive. In a metaphorical sense, we can
consider them as ‘living dead’ or ‘zombie cells’. Stabilized
apoptotic retain many of the hallmark characteristics of
genuine apoptotic cells such as plasma membrane imperme-
ability, integrity of plasma membrane proteins, low intracel-
lular calcium levels, plasma membrane potential, PS
externalization and ability of being phagocytosed.
Interest in apoptosis research has increased considerably
recently for a number of reasons including development of
therapeutic treatments, cell culture technology development,
metabolic engineering of mammalian cells and gene therapy.
Furthermore, apoptotic cells play important roles in biomedi-
cine because of their characteristics, and they are being
widely used to evaluate the cytotoxic effects of various
compounds by quantifying apoptotic cells by flow cytometry.31
However, this determination is often affected by the process of
cell manipulation (treatments for harvesting, cell centrifuga-
tion, cell pipetting and so on), especially in adherent cell
cultures required for flow cytometry assays that disrupts
plasma membrane permeability and leads apoptotic cells to
secondary necrosis.32 Therefore, accurate and reliable
apoptosis quantifications are particularly difficult in adherent
cell cultures. Stabilization of apoptotic cells before cell
harvesting allows a more accurate and reliable quantification
of the actual number of apoptotic cells or the correct
AMN stabilization
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determination of biochemical parameters of genuine apoptotic
cells such as mitochondrial membrane potential, intracellular
calcium concentration, pH, caspase activity and many others,
without the interference of plasma membrane disruption and
subsequent secondary necrosis.
Moreover, apoptotic cells are currently used for various
forms of therapy, primarily with the aim of inducing immuno-
logical tolerance in the recipient individual.33 The stabilization
of apoptotic cells before administration may help to ensure
that the inoculated apoptotic cells will retain their
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Figure 5 Effect of apoptosis stabilization on PS externalization and interaction with phagocytes. (a) Fluorescence microscopy of microtubules and PS externalization in control
cells, apoptotic cells without stabilization, stabilized apoptotic cells and control secondary necrotic cells after 72 h of incubation. H460 cells were grown on glass coverslips and
apoptosis was induced as described in the enriched apoptotic assay in the Materials and Methods. Secondary necrotic cells were collected from the floating cells in the medium after
treatment and cytospined onto a slide. Stabilized apoptotic cells were treated with 1 mM taxol, 50mM Zn2þ and 50mM CoQ. Then, cells were fixed and immunostained with anti
b-tubulin (red), and PS externalization was revealed by staining with Annexin V-FITC. Nuclear morphology was revealed by staining with Hoechst 33342 (1mg/ml). Bar¼ 15mm).
(b) PS externalization was quantified by flow cytometry as described in the Materials and Methods. Data represent the means±S.D. of three independent experiments.
(c) Wide-field images of CellTracker Green-labeled control and stabilized apoptotic H460 cells (white arrows) interacting with THP-1 macrophages (red arrows). Bars¼ 15mm.
(d) Proportion of THP-1 macrophages interacting and engulfing control and stabilized apoptotic H460 cells. CellTracker Green-labeled H460 cells were induced into apoptosis by
CPT/cytochalasin as described in the Materials and Methods. Stabilized apoptotic cells were treated with 1mM taxol, 50mM Zn2þ and 50mMCoQ. Control and stabilized apoptotic
cells were then co-incubated with THP-1 macrophages. Nuclear morphology was revealed by staining with Hoechst 33342 (1mg/ml). Data represent the means±S.D. of three
independent experiments. *Po0.01, significant differences with respect to control cells; aPo0.01, significant differences with respect to apoptotic cells without stabilization
Figure 4 PMCA-4 integrity, mitochondrial membrane potential, ATP and ROS levels after apoptosis stabilization. (a) Fluorescence microscopy of PMCA-4 in control cells,
apoptotic cells without stabilization, stabilized apoptotic cells and control secondary necrotic cells after 72 h of incubation. H460 cells were grown on glass coverslips and apoptosis
was induced as is described in the enriched apoptotic assay in the Materials and Methods. Secondary necrotic cells were collected from the floating cells in the medium after
treatment and cytospined on a slide. For stabilization, apoptotic cells were treated with 1mM taxol, 50mMZn2þ and 50mMCoQ. Then, cells were fixed and immunostained with anti
PMCA-4 (green) and anti b-tubulin (red). Nuclear morphology was revealed by staining with 1mg/ml Hoechst 33342. Bar¼ 15mm. (b) Intracellular calcium levels were measured by
flow cytometry using the calcium indicator FLUO-4 (1mM) in control cells, apoptotic cells without stabilization, stabilized apoptotic cells and control secondary necrotic cells after 72 h
of incubation. The y axis of the calcium graph represents the fluorescence intensity of the samples relative to the background intensity. (c) Mitochondrial membrane potential in
stabilized apoptotic cells. Mitochondrial membrane potential was measured in control cells, apoptotic cells without stabilization, stabilized apoptotic cells and control secondary
necrotic cells after 72 h of incubation. Apoptosis was induced as described in the enriched apoptotic assay in theMaterials andMethods. Secondary necrotic cells were collected from
the floating cells in the medium after treatment. Stabilized apoptotic cells were treated with 1mM taxol, 50mM Zn2þ and 50mMCoQ. Mitochondrial membrane potential (Dcm) was
determined by MitoTracker Red staining and flow cytometry analysis as described in the Materials and Methods. The y axis of the MitoTracker graph represents the fluorescence
intensity of the samples relative to the background intensity. (d) ATP levels were measured in control cells, apoptotic cells without stabilization, stabilized apoptotic cells and control
secondary necrotic cells after 72 h of incubation. ATP levels were measured as described in the Materials and Methods. Results were expressed as percentage with respect to ATP
levels in control cells. (e) ROS levels were measured in control cells, genuine apoptotic cells, apoptotic cells without stabilization, stabilized apoptotic cells and control secondary
necrotic cells after 72 h of incubation. ROS levels were measured by MitoSOX staining coupled to flow cytometry analysis as described in the Materials and Methods. The y axis of
the MitoSOX graph represents the fluorescence intensities of MitoSOX cell samples relative to unstained cells. Data represent the means±S.D. of three independent experiments.
*Po0.01, significant differences with respect to control cells; aPo0.01, significant differences with respect to apoptotic cells without stabilization
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characteristic features until they are phagocytosed by macro-
phages. The administration of stabilized apoptotic cells can
also be used for delivering substances of interest such as
therapeutic proteins (for protein replacement therapy) or
drugs to recipient macrophages.34
There are forms of death that by their nature impair the
correct formation of the AMN (e.g., mitochondrial toxics and
cold exposure)21 and as a result apoptotic cells are not able to
maintain plasma membrane integrity and undergo secondary
necrosis that may cause serious side effects. Apoptotic cell
stabilization may allow the development of therapies for the
correct formation and stabilization of AMN, thus promoting a
more physiological and controlled type of cell death. Based on
the above arguments, there is a need to provide compositions
and methods for the stabilization of apoptotic cells.
In summary, we have demonstrated that apoptotic cells can
be stabilized for reliable detection and quantification of
apoptosis in cultured cells. Stabilization of apoptotic cells
may also allow a safer administration of apoptotic cells in
clinical applications and opens new avenues in the functional
reconstruction of apoptotic cells for longer preservation.
Materials and Methods
Reagents. CPT was purchased from Alexis Corporation (Nottingham, UK).
Cytochalasin, taxol, ZnSO4, Phalloidin-coumarin, trypsin, anti-ROCK-1, anti-actin,
coenzyme Q10 and anti-a-tubulin were purchased from Sigma Chemical Co. (St.
Louis, MO, USA). Anti-b-tubulin antibodies were from Chemicon International
(Temecula, CA, USA). Hoechst 33342, FITC-labeled goat anti-mouse and
tetramethyl rhodamine goat anti-rabbit antibodies, Dead Red reagent and FLUO-4
were purchased from Molecular Probes (Eugene, OR, USA). Anti-active caspase-3,
anti-active caspase-7, anti-caspase-9 and anti-cleaved PARP were obtained from
Cell Signaling Technology (Beverly, MA, USA). Anti- focal adhesion kinase (FAK),
anti-PMCA-4, anti-a-spectrin and anti-paxilin were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Anti-GADPH was purchased from
Calbiochem Merck Millipore (Darmstadt, Germany).
Cell culture. Non-small lung cancer cell line, H-460, was a gift from Dr. PJ
Woll (CRC Department of Clinical Oncology, City Hospital, Nottingham, UK). Cells
were cultured in RPMI medium supplemented with penicillin, streptomycin and
10% fetal bovine serum at 371C.
Enriched apoptotic assay. Apoptosis was induced to cells by treatment
with 10mM CPT, an anticancer drug that inhibits the DNA enzyme topoisomerase I.
To increase the proportion of attached apoptotic cells with AMN formation, H460
cells were treated with CPTþ cytochalasin (2 mM) for 48 h. To prevent cell cycle
effects, cytochalasin was added 24 h after CPT treatment. Inhibiting actin
polymerization, and consequently actin contraction with cytochalasin, CPT induced
apoptosis but apoptotic cells maintained the spread state and remained attached
to the flask or slide.35 Secondary necrotic cells were collected from the floating
cells in the medium after CPT treatment.
Apoptotic stabilizer. Apoptotic cell stabilization was performed by treating
apoptotic cells with: 1 mM taxol, 50mM Zn2þ (ZnSO4) or 50mM CoQ, or the
combined treatment of the three compounds.
Analysis of apoptosis. Apoptosis was defined by the occurrence of cells
with nuclear condensation and fragmentation by Hoechst staining, but retaining
plasma membrane integrity (measured by exclusion of the membrane-imperme-
able dye, Dead Red reagent). Apoptosis was also assessed by caspase activation,
cytochrome c release, lack of actin cytoskeleton, presence of apoptotic
microtubules and/or cell morphology by phase-contrast microscopy. Primary
necrosis was defined as a loss of plasma membrane integrity without signs of
nuclear condensation or fragmentation. Secondary necrosis was determined by
scoring over time apoptotic cells that became permeable to the Dead Red reagent.
Cells were counted for up to 48 h after CPT/cytochalasin exposure. In each case,
10 random fields and more than 100 cells were counted. To differentiate between
genuine apoptotic cells and cells in secondary necrosis, Dead Red reagent was
added to the cells 10min before fixation.
Immunofluorescence studies. H460 cells were grown on 1mm (Thermo
Scientific Gold Seal, Waltham, MA, USA) glass coverslips for 24–48 h in RPMI
containing 10% FBS. After treatments, cells were rinsed once with PBS, fixed in
3.8% paraformaldehyde for 5 min at room temperature and permeabilized in 0.1%
saponin for 5 min. For immunostaining, glass coverslips were incubated with
primary antibodies diluted 1 : 100 in PBS for 1–2 h at 371C in a humidified
chamber. Excess antibody binding was removed by washing the coverslips with
PBS (three times, 5min). The secondary antibody, a FITC-labeled goat anti-
mouse antibody or a tetramethyl rhodamine goat anti-rabbit (Molecular Probes),
diluted 1 : 100 in PBS, were added and incubated for 1 h at 371C. Coverslips were
then rinsed with PBS for 3 min, incubated for 1min with PBS containing Hoechst
33342 (1mg/ml) and washed with PBS (three 5-min washes). Finally, the
coverslips were mounted onto microscope slides using Vectashield Mounting
Medium (Vector Laboratories, Burlingame, CA, USA) and analyzed using an
upright fluorescence microscope (Leica DMRE, Leica Microsystems GmbH,
Wetzlar, Germany). Deconvolution studies and 3D projections were performed
using a DeltaVision system (Applied Precision, Issaquah, WA, USA) with an
Olympus IX-71 microscope with  100 objective/1.35 NA and  60 objective/1.40
NA (Olympus, Tokyo, Japan) and filters set for DAPI, fluorescein isothiocyanate,
and rhodamine provided by Applied Precision. Acquired z planes were separated
by 0.3mm, and an average of 50 planes was taken for each nucleus. The 3D
stacks were deconvolved using the Softworx software algorithm (conservative ratio
method, 10 iterations; Applied Precision).
Western blotting analysis. Whole cellular lysates were prepared in a
buffer, with gentle shaking, composed of 0.9% NaCl, 20mM Tris-HCl, pH 7.6,
0.1% Triton X-100, 1 mM phenylmethylsulfonylfluoride and 0.01% leupeptine.
Electrophoresis was carried out in a 10–15% acrylamide SDS-PAGE. Proteins
were transferred to Immobilon membranes (Amersham Pharmacia, Buckingham-
shire, UK). Proteins were electrophorezed, transferred to nitrocellulose
membranes and, after blocking overnight at 41C, incubated with the respective
antibody solution at 1 : 1000 dilutions. Then, membranes were probed with their
respective secondary antibody (1 : 2500). Immunolabeled proteins were detected
by using a chemioluminiscence method (Bio-Rad, Hercules, CA, USA). Protein
was determined by the Bradford method.36
Cell content release: LDH determination. Plasma membrane integrity
and cell content release was monitored by measuring LDH activity into the
incubation medium. This was done using a commercial kit (CytoTox 96 Non-
Radioactive Cytotoxicity Assay from Promega (Madison, WI, USA).
Determination of intracellular calcium levels by flow cytometry.
H460 cells were incubated for 60min at 371C in medium supplemented with 1mM
FLUO-4, AM. Cells were then washed three times with RPMI medium, fixed with
3.8% paraformaldehyde and analyzed by flow cytometry using an EPICS Elite flow
cytometer (Beckman-Coulter, Hialeah, FL, USA).
Measurement of Dwm by flow cytometry. H460 cells were incubated
for 60min at 371C in medium supplemented with 1mm Mitotracker Red (Molecular
Probes). Cells were then washed three times with RPMI medium, fixed with 3.8%
paraformaldehyde and analyzed by flow cytometry.
ATP determination. ATP levels were determined by using a luciferase-
based assay according to the directions of Molecular Probes, using a Tuner
Designs Luminometer TD 20/20 (Sunnyvale, CA, USA).
Measurement of intracellular generation of ROS. Mitochondrial
ROS generation in fibroblasts was assessed by MitoSOX, a red mitochondrial
superoxide indicator. Once in the mitochondria, MitoSOX red reagent is oxidized
by superoxide and exhibits red fluorescence. Approximately 1 106 cells were
incubated with 1 mM MitoSOX for 30min at 371C, washed twice with PBS,
resuspended in 500ml of PBS and analyzed by flow cytometry (excitation at
510 nm and fluorescence detection at 580 nm). Specificity of MitoSOX for
superoxide has been shown by the manufacturer, and its mitochondrial localization
was tested by co-staining with MitoTracker Green (data not shown).
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Electrophysiological recordings. Somatic whole-cell patch-clamp
recordings were made from healthy (control), nonstabilized and stabilized
apoptotic H460 cells and necrotic cells. These cells were visually identified by
IR-DIC (infrared-differential interference contrast) microscopy using a 40 water
immersion objective. Cells were perfused at a flow rate of 3.5 ml/min with a
solution containing (in mM): NaCl 126; KCl 3; NaH2PO4 1.25; MgSO4 2; CaCl2 2;
NaHCO3 26; glucose 10, pH 7.2–7.4; bubbled with carbogen gas (95% O2/5%
CO2). All experiments were performed at 371C. Patch electrodes were made from
borosilicate glass, and had a resistance of 4–7MO when filled with (in mM):
potassium gluconate 110; HEPES 40; NaCl 4; ATP-Mg 4; GTP 0.3 (pH 7.2,
290mOsm). Cells were voltage clamped, using a Multiclamp 700B amplifier
(Molecular Devices, Foster City, CA, USA). Access resistance was regularly
monitored during recordings, and cells were rejected if it changed 415% during
the experiment. Data were filtered at 2 kHz, digitized at 10 kHz and stored on a
computer using pClamp software (Molecular Devices). Membrane potentials (Vm)
of the cells were recorded by using the current-clamp mode of the amplifier. Vm
were measured continuously during the experiments. Average values indicated in
the text correspond to Vm at 5 and 15min after the beginning of the recordings.
Potentials were obtained by applying a series of test pulses from a holding
potential of  60mV (control healthy cells) and  20mV (apoptotic cells) with
10mV increases in pulse amplitude per step.
Determination of PS externalization. PS translocation from the inner to
the outer leaflet of the plasma membrane is one of the earliest apoptotic features.
We used the PS-binding protein Annexin V conjugated with FITC to identify PS
exposure in H460 cells. The binding of annexin V to cell surface PS was detected
with a commercial Annexin Apoptosis Kit (Santa Cruz Biotechnology) according to
the manufacturer’s instructions. To distinguish cells that had lost membrane
integrity, propidium iodide (PI) was added to a final concentration of 10 mg/ml
immediately before analysis. Apoptotic cells were identified either by fluorescence
microscopy or by flow cytometry. Hoechst 33342 (1 mg/ml) staining was used to
reveal nuclear condensation/fragmentation.
Phagocytosis assays. CellTracker-labeled H460 cells (Molecular Probes)
that adhered to glass coverslips were induced into apoptosis by CPT/cytochalasin
treatment and then were incubated for 1 h in the absence or presence of
colchicine or colchicine plus z-VAD. Then, cells were washed and co-incubated
with PMA-differentiated THP-1 macrophages (150 000 cells/well). Floating
apoptotic cells representing secondary necrotic cells were cytospined onto
coverslips and also co-incubated with PMA-differentiated THP-1 macrophages.
After 8 h of co-incubation at 371C, coverslips were washed extensively in PBS and
cells were fixed in 3.8% paraformaldehyde. The number of THP-1 macrophages
interacting (bound and engulfed) and engulfing cell fragments was calculated in 10
random fields in triplicate by fluorescence and phase-contrast microscopy.
Apoptosis flow cytometry assay. We followed a standard protocol
supplied by Santa Cruz Biotechnology (Annexin V-FITC: sc-4252 FITC). Control
and apoptotic H460 cells were trypsinized and transferred to a 15ml conical tube.
Cells were pelleted by low speed centrifugation at 1500 r.p.m. for 5min. Gently
wash in medium containing serum. Next, cells were washed once with PBS and
resuspended in 1 Assay Buffer at a concentration of 1 106 cells/ml. Then,
100ml aliquot of cells (1 105 cells) was transferred to a 5-ml culture tube and
1mg/ml of Annexin V-FITC and 1mg/ml 7-ADD was added. Recommended
negative controls for flow cytometry include: (1) no Annexin V-FITC and no 7-ADD;
(2) Annexin V-FITC alone and (3) 7-ADD alone. Subsequently, samples were
gently vortexed and incubated for 15min at room temperature in the dark.
Immediately, samples were analyzed by flow cytometry.
Statistical analysis. All results are expressed as means±S.D. unless
stated otherwise. Two-tailed Student’s t-tests (paired and unpaired, according
to samples) or ANOVA variance analysis were used as appropriate for
statistical analysis. Only P-values of o0.05 were considered as statistically
significant.
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